{"chebi_id":"45716","chebi_name":"vorinostat","chebi_synonyms":["octanedioic acid hydroxyamide phenylamide","suberoylanilide hydroxamic acid","Zolinza","SHH","SAHA","Suberanilohydroxamic acid","vorinostatum","N-hydroxy-N'-phenyloctanediamide"],"diffprof_id_observed":["MTBLS1411_0001_00000001","MTBLS2145_0002_00000029","MTBLS2406_0002_00000009","MTBLS2871_0002_00000009","MTBLS3963_0001_00000001","MTBLS4967_0001_00000003","MTBLS4980_0002_00000006","MTBLS5828_0002_00000001","MTBLS6890_0002_00000001"],"diffprof_id_var_observed":["MTBLS1411_0001_00000001","MTBLS2871_0002_00000009","MTBLS5828_0002_00000001"],"inchikey":"WAEXFXRVDQXREF-UHFFFAOYSA-N","inn_name":"vorinostat","iupac_name":"<em>N</em>-hydroxy-<em>N</em>'-phenyloctanediamide","num_study_observed":9,"reactome_ids":["R-HSA-1643685","R-HSA-3214815","R-HSA-3247509","R-HSA-4839726","R-HSA-5663205","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446"],"reactome_names":["Disease","HDACs deacetylate histones","Chromatin modifying enzymes","Chromatin organization","Infectious disease","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways"],"study_id_observed":["MTBLS1411","MTBLS2145","MTBLS2406","MTBLS2871","MTBLS3963","MTBLS4967","MTBLS4980","MTBLS5828","MTBLS6890"],"study_id_var_observed":["MTBLS1411","MTBLS2871","MTBLS5828"],"synonym_name":"suberoylanilide hydroxamic acid"}
